Back
Zenas BioPharma 10K Form
Sell
29
ZBIO
Zenas BioPharma
Last Price:
11.98
Seasonality Move:
1.54%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive ZBIO News And Ratings
See the #1 stock for the next 7 days that we like better than ZBIO
ZBIO Financial Statistics
Sales & Book Value
| Annual Sales: | $50M |
|---|---|
| Cash Flow: | $-30.99M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $-7.54 |
| Price / Book: | 0 |
Profitability
| EPS (TTM): | -1.64380 |
|---|---|
| Net Income (TTM): | $-54.76M |
| Gross Margin: | -- |
| Return on Equity: | 0% |
| Return on Assets: | 0% |
Zenas BioPharma Earnings Forecast
Key Zenas BioPharma Financial Ratios
- The Research & Development expenses have been 120.07% of Revenue.
- The Net Earning history of ZBIO is -74.25% of Total Revenues.
- Per Share Earnings over the last 2 years have been positive in 1 years.
Zenas BioPharma Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | ZBIO |
| CUSIP: | 74347B |
| Website: | zenasbio.com |
Debt
| Debt-to-Equity Ratio: | 0 |
|---|---|
| Current Ratio: | 0 |
| Quick Ratio: | 0 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
ZBIO Technical Analysis vs Fundamental Analysis
Sell
29
Zenas BioPharma (ZBIO)
is a Sell
Is Zenas BioPharma a Buy or a Sell?
-
Zenas BioPharma stock is rated a Sell
The current Zenas BioPharma [ZBIO] share price is $12.00. The Score for ZBIO is 29, which is 42% below its historic median score of 50, and infers higher risk than normal.